A 19-year-old Aboriginal woman living in a remote community has a history of acute rheumatic fever and established rheumatic mitral regurgitation. She weighs 55 kg and has no penicillin allergy. According to current Australian rheumatic heart disease recommendations, what is the preferred regimen for secondary prophylaxis against recurrent acute rheumatic fever?